Dual oligopeptides modification mediates arsenic trioxide containing nanoparticles to eliminate primitive chronic myeloid leukemia cells inside bone marrow niches
Publication date: Available online 26 February 2020Source: International Journal of PharmaceuticsAuthor(s): Luhui Fan, Cong Liu, Anzhi Hu, Jing Liang, Fanzhu Li, Yang Xiong, Chao-Feng Mu
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Drugs & Pharmacology | Leukemia | Nanotechnology